Drugs / MSC
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT06788470 | Aug 2024 → Aug 2027 expected | bronchopulmonary dysplasia | The Children's Hospital of Zhejiang University School of Medicine | Recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MSC | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06788470 ↗ |
| Known as | MSCs | “Intratracheal administration of umbilical cord-derived mesenchymal stem cells (MSCs).” NCT06788470 ↗ |
| Route | Other | “Intratracheal administration of umbilical cord-derived mesenchymal stem cells (MSCs).” NCT06788470 ↗ |